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Background: Following enhanced malaria control measures, such as nationwide free distribution of insecticide-treated
bed nets (ITN) by the government of Cameroon, its impact on malariometric and red cell indices in children ≤14 years
in Muea, in the Mount Cameroon area was evaluated.
Methods: Two cross-sectional studies were conducted during the malaria transmission season (March-July) in 2006
(baseline) and 2013 (follow-up), respectively. The investigative methods included the use of a questionnaire to assess
ITN use and coverage, clinical evaluation and laboratory investigations. Blood sample collected from each child was
used for the preparation of blood films for detection of malaria parasites and density as well as full blood count
determination using standard procedures and also an automated haematology analyzer.
Results: The majority of children (81.5%) possessed an ITN in 2013. The proportion of effective users of ITN
increased significantly from 20.9% (CI = 17.3-25%) in 2006 to 35.2% (CI = 31–39.7%) in 2013. The highest relative
risk reduction in prevalence during the follow-up study was observed in malaria anaemia (79%, CI = 58.0-69.1%
[69.1 to 14.5%]), followed by gametocytaemia (71.6%, CI = 58.9-80.3% [25.6 to 7.3%]), anaemia (64%, CI = 58.0-69.1%
[80.1 to 28.9%]), and malaria parasitaemia (57.2%, CI = 51.4-62.3% [85.4 to 36.6%]). In the baseline survey, the prevalence
of splenomegaly was significantly highest (χ2 = 18.3, P <0.001) in the youngest group of children while in the follow-up
study, it was highest in the oldest (χ2 = 6.03, P = 0.049). The overall prevalence of mild, moderate and severe anaemia
in the study population at baseline (59.6, 14.9, 6.3%) decreased significantly (P <0.001) to 24.4, 2.7 and 1.3%, respectively
during the follow-up with the highest relative risk reduction in prevalence occurring in moderate anaemia (82.1%,
CI = 67.3-90.2% [14.9 to 2.7%]). Microcytic anaemia also decreased significantly (P <0.001) from 56 to 7.7% during the
follow-up survey.
Conclusion: Following interventions, anaemia (moderate to severe) was a more sensitive measure to changes in
malaria exposure and children between 11–14 years of age experienced a significant increase in malaria-related
morbidity.
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The estimates of malaria burden are based on malario-
metric indices, such as prevalence of malaria parasitaemia,
spleen rate and anaemia in defined risk groups [1]. Child-
hood anaemia may be a useful indicator of the burden of
malaria and of the progress in malaria control [2]. As an
intra-erythrocytic parasite of blood, Plasmodium induces
haematological alterations. It is essential to monitor these
alterations in order to assess the impact of malaria control
interventions.
There are many preventive measures of malaria both
at community and individual level, with the most prom-
ising being insecticide-treated bed nets (ITNs) [3-5]. The
use of ITNs may be easier to implement and sustain
than available alternative vector control methods, such as
environmental sanitation. This is because of the immediate
perceptible benefits to the user in personally preventing
them from the nuisance of mosquitoes, as well as their
killing effect on head lice [6] and bed bugs [7]. In order to
be protected, individuals must not only own ITNs but also
use them. As high coverage rates are needed to realize
the full potential of vector control, the World Health
Organization (WHO) recommends that in areas targeted
for malaria prevention, and for which ITNs are selected as
the vector control method, they should be made available
to all people at risk, i.e., universal access [8]. In Cameroon,
a high (>70%) percentage of the population potentially
covered by ITNs distributed in 2011 was reported, yet no
decrease in admissions and deaths were registered [9].
A strong association between interventions and their
impact on malaria morbidity and mortality has been re-
ported in Sao Tome and Principe [9]. When full coverage
is achieved, ITNs have been reported to reduce clinical
episodes of malaria caused by Plasmodium falciparum
and Plasmodium vivax infection by 50% on average (range
39-62%), as well as reducing the prevalence of high density
parasitaemia [3]. Despite efforts made by the National
Malaria Control Programme (NMCP) to curb the disease
burden, the prevalence is seemingly not on the increase
but still a public health problem. Following substantial
investments by the government of Cameroon in malaria
control, coupled with the lack of population-based surveys
or specific studies of the impact of interventions, the need
for evaluation of intervention is critical. The objective of
this study was to evaluate the impact of enhanced malaria
control measures by the free distribution of ITNs on
malariometric and red cell indices in children ≤14 years in
Muea, in the Mount Cameroon area.
Methods
Study area and participants
The study was carried out in Muea village, a semi-rural
setting in the Mount Cameroon area. The coordinates
of the study area ranged from altitude 540 m, latitude04°10.464′N, longitude 009°18.168′E to 556 m, 04°
10.015′N and 009°18.009′E. The study area has been
described in detail by Sumbele et al. [10]. The children
from the community who participated in the study
weighed >5 kg, were ≤14 years old, free from other
clinical conditions not related to malaria and sickle test
negative. Children who presented with fever, joint
pains, headache, malaise, abdominal pain, nausea, and
vomiting were considered to be symptomatic (clinical
malaria).Study design
Following several control programmes, including the
free distribution of ITNs (Figure 1) by the government
of Cameroon through the NMCP, two cross-sectional
studies were conducted during the malaria transmission
season (March-July) in Muea, a semi-rural community in
the Mount Cameroon area. The first cross-sectional study
(baseline) was carried out in 2006 following the free distri-
bution of ITNs to malaria-vulnerable groups (pregnant
women and children under five years) only, in selected
regions of the country. A second cross-sectional study
(follow-up) was conducted in 2013 following an up-
scale systematic distribution of ITN and long-lasting,
insecticidal nets (LLINs) to all households in all health
districts and the institution of free malaria treatment
for children under five years of age.
At the start of each study, the parents, guardians and
children were educated at their various neighbourhoods.
During education, the study protocol was explained and
the benefits of participating in the study highlighted.
Children were enrolled into the study only when par-
ent or guardian signed the assent form or gave a verbal
consent. Thereafter the children were clinically evalu-
ated and their parent/caregivers interviewed using a
semi-structured questionnaire to obtain information
on ITN possession and use. Blood samples were col-
lected for thick and thin smear microscopy as well as a
standard full blood count. Labelled blood samples were
transported on ice in a cool box of temperature be-
tween 8-10°C to the University of Buea Malaria Research
Laboratory for further analyses.Questionnaire
A semi-structured questionnaire was administered to the
participant/parent/guardians/caregiver to obtain informa-
tion about ITN/LLINs use, its state, various malaria con-
trol measures and occurrence of malaria since they started
using the nets. Children, who had good nets (potent ITN/
LLINs, without hole/tears) that were used regularly, were
considered effective users while children who had good
nets but used them irregularly or had torn nets were con-
sidered as ineffective users.
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Figure 1 Relevant malaria control interventions in Cameroon.
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The clinical evaluation carried out by trained medical
personnel in their homes consisted in part by the
measurement of body temperature and examination of
the spleen. Axillary body temperature was measured
using a digital thermometer. A child with a body
temperature ≥37.5°C was considered febrile. Ages of
the children were obtained from their mothers and
verified from their birth certificates. The tip of the
spleen was felt by pressing the abdomen under the left
coastal border and splenomegaly was graded according
to the classification of Hackett [11].
Laboratory methods
Approximately 4–5 ml of blood sample was collected
from the children by venipuncture into 5 ml sterile dis-
posable syringes and dispensed into micro-containers
or vacutainers containing ethylenediaminetetraacetate
(EDTA) solution. Drops of whole blood were dispensed
immediately on slides to prepare blood films. The thick
and thin blood smears prepared on glass slides at the
time of blood sampling were stained with Giemsa and
examined following standard protocols [12]. Parasite
density was determined on the basis of number of
parasites per 200 leukocytes on thick blood film with
reference to subjects’ white blood cell counts (WBC).
If gametocytes were seen, the count was extended to
500 leukocytes [13]. In 2006, haemoglobin (Hb) con-
centration was measured in the field using a Stanbio
STAT-SiteR Test Kit (STAT-site MHgb Meter, Stanbio
Laboratory, Texas, USA) following the manufacturer’s
instructions. Also WBC and red blood cell counts (RBC)
were determined using the improved Neubauer haemocyt-
ometer as described by Cheesbrough [12] and Dacie and
Lewis [14]. In 2013, a complete blood count: RBC, WBC,
Hb, haematocrit (Hct), platelet, mean corpuscular volume
(MCV), mean corpuscular haemoglobin (MCH), and
mean corpuscular haemoglobin concentration (MCHC)
was run following the manufacturer’s instructions usingan automated haematology analyzer, the Beckman Coulter
counter (URIT 3000).
Definitions and end points
 Fever was defined as temperature ≥37.5°C;
 Asymptomatic malaria (AM) was defined as the
presence of Plasmodium with an axillary
temperature of <37.5°C;
 Clinical malaria (CM) was defined as the presence of
any species of Plasmodium, with an axillary temperature
of ≥37.5°C or reported fever in previous 48 hours;
 Parasitaemia was categorized as low (<1,000 parasite/μL
blood), moderate (1,000-4,999 parasites/μL blood) and
high (≥5,000 parasites/μL blood);
 A Hb level of <11 g/dL was classified as anaemic
and further categorized as mild (Hb between 10.1
and 10.9 g/dL), moderate (Hb between 7.0 and
10.0 g/dL) and severe (Hb <7 g/dL) anaemia [12,15];
 Malarial anaemia (MA) was defined as children with
Hb <11 g/dL and malaria parasite positive [16];
 Microcytosis was defined as MCV of less than 73 fl
[17];
 Hypochromasia was defined as a MCHC of less than
320 g/L [18].
Data analysis
Data were entered into spreadsheets using Microsoft
Excel and analysed with the IBM Statistical package for
Social Sciences (SPSS) version 19 (SPSS Inc., Chicago, IL,
USA). Data were summarized into means and standard
deviations (SD), and percentages were used in the evalu-
ation of the descriptive statistics. Proportions were com-
pared using the Chi-square test (χ2). Parasitaemia was
log transformed before analysis. Means were compared
using independent sample t-test and analysis of variance
(ANOVA) where appropriate. The 95% confidence inter-
val (CI) for the difference between two proportions and
relative risk reduction were calculated using a Microsoft
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Newcombe-Wilson method [19,20]. The relative risk
reduction and its confidence limits were obtained as one
minus the relative risk and the values presented as per-
centages (%) by multiplying by a hundred (100).
Ethical considerations
Before commencement of each study, administrative
clearance was obtained from the South West Regional
Delegation of Public Health. The institutional review
board hosted by the Faculty of Health Sciences, University
of Buea issued the ethical clearance document. Additional
authorization was obtained from the local health commit-
tee and the village chief. Children participated in the study
if a parent or guardian signed the informed consent/assent
form. The parents or guardians and their children were in-
formed that their participation in the study was voluntary
and they could withdraw at any time without explanation.
Results
Characteristics of study populations
In 2006, a total of 411 children (215, 52.3% males and
196, 47.7% females) ≤14 years with a mean age of 6.4 (7.4)
years were examined for the presence of malaria parasites
and some malaria-related indices. Two-hundred and twenty
(53.5%) of the children were age ≤ five years while 134
(32.6%) and 57 (13.9%) belonged to the six to ten and
11–14 years age groups, respectively. A total of 129
(31.4%, CI = 27.1-36%) children possessed or used an
ITN. Only 86 (20.9%, CI = 17.3-25%) of them used them
effectively. The proportion of effective users in the dif-
ferent age groups was comparable (P = 0.82).
In the follow-up study in 2013, 454 children (211,
46.5% males and 243, 53.5% females) ≤14 years with a
mean age of 6.7 (3.4) years were examined. Of these,
177 (39.0%), 205 (45.2%) and 72 (15.9%) of the children
were in the ≤ five, six to ten and 11–14 years age
groups, respectively. The majority of the children (81.5%,
CI = 77.7-84.8%) in the community possessed or used an
ITN. The proportion of effective users of ITN in 2013
increased significantly from 20.9% (86, CI = 17.3-25%) in
2006 to 35.2% (160, CI = 31–39.7%). The proportion of ef-
fective users was significantly highest (χ2 = 9.52, P = 0.01)
in the < five years age group (42.4%, CI = 35.3-49.7%) when
compared with the six to ten (33.7%, CI = 27.5-40.4%) and
the 11–14 years (22.2%, CI = 14.2-33.1%) age groups.
Variation in malariometric indices
The prevalence of fever, malaria parasitaemia, gameto-
cytaemia, splenomegaly, CM, AM, anaemia, and MA
decreased significantly (P <0.05) in 2013 when compared
with the baseline data in 2006 (Table 1). In decreasing
order, the highest relative risk reduction in prevalence
during the follow-up study in 2013 was observed in MA(79%, CI = 58.0-69.1%), where MA prevalence decreased
from 69.1 to 14.5%. This was followed by gametocytaemia
(71.6%), anaemia (64%), CM (62.2%), AM (60.6%), malaria
parasitaemia (57.2%), and splenomegaly (39.3%) as shown
on Table 1. The prevalence of fever showed the least rela-
tive risk reduction in prevalence (23.5%).
The trends in prevalence of fever and gametocytaemia
in the different age groups were comparable at baseline
and in the follow-up study. Although not statistically sig-
nificant, the highest prevalence of malaria parasite was
observed in children between 11–14 years of age in the
follow-up study (40.3%, CI = 29.7-51.8%), while in the
baseline study children in the six to ten years age group
had the highest prevalence (88.1%, CI = 81.5-92.5%) as
indicated in Table 2.
In the baseline survey, the prevalence of splenomegaly
was significantly highest (χ2 = 18.3, P <0.001) in the
youngest group of children while in the follow-up study,
the highest prevalence of splenomegaly that approached
significance (χ2 = 6.03, P = 0.049) was observed in the oldest
group of children (Table 2). The prevalence of splenomeg-
aly in children in the 11–14 years age group was higher
(χ2 = 3.71, P = 0.054) in the follow-up study (23.6%, CI =
15.3-36.5%) than at the baseline (10.5%, CI = 4.9-21.1%)
with an odds ratio of 2.63 (CI = 0.96-7.18).
The prevalence of anaemia in both study periods de-
creased significantly (P <0.05) with increased age (Table 2).
The highest relative risk reduction in prevalence occurred
in the 11–14 years age group (89.9%, CI = 75.9-95.7%) when
compared with the < five years (55.0%, CI = 45.2-63.1%) and
six to ten years (63.3%, 53.6-70.9%) age groups.
At baseline a comparison of MA prevalence within the
age groups showed no significant difference (P >0.05) while
in 2013, the prevalence decreased significantly (P <0.001)
with an increase in the age group with children in the
11–14 years age group having a 97.7% (CI = 83.5-99.7%)
relative risk reduction in prevalence (Table 2).
Although not statistically significant, the asexual geomet-
ric mean parasite density (GMPD)/μL of blood in 2013
was higher (834.8) than the baseline value (789.9). As
shown in Table 3, the decrease in GMPD with increased
age was statistically significant (P <0.01) at baseline, while
in the follow-up study, no significant difference in neither
GMPD with age group nor a trend was observed.
The disparity in prevalence of low, moderate and high
asexual malaria parasite at baseline (60.1%, CI = 54.9-
65.1% [210]; 27.6%, CI = 23.2-32.5% [97]; 12.3%, CI = 9.2-
16.1% [43]) and follow-up (56.5%, CI = 48.8-63.9% [91];
29.8%, CI = 23.3-37.3% [48] and 13.7% CI = 9.2-19.8% [22],
respectively) was not significant (P = 0.74).
Variation in red cell indices
Between the baseline survey and the follow-up study,
the overall mean Hb concentration significantly increased
Table 1 Variation in prevalence of malariometric indices
Variable Baseline (2006) Follow-up (2013) χ2 P-value Relative risk reduction Odds ratio
Fever
% (n) 28.2 (116) 21.6 (98) 0.03a 23.5 0.7
CI 24.1-32.8 18.1-25.6 3.4-39.4 0.51-0.96
Malaria parasitaemia
% (n) 85.4 (351) 36.6 (166) < 0.001c 57.2 0.10
CI 81.7-88.5 32.3-41.1 51.4-62.3 0.07-0.14
Gametocytaemia
% (n) 25.6 (105) 7.3 (33) < 0.001c 71.6 0.23
CI 21.6-30.0 5.2-10.0 58.9-80.3 0.15-0.35
Splenomegaly
% (n) 23.6 (97) 14.3 (65) < 0.001c 39.3 0.54
CI 19.8-27.9 11.4-17.8 19.4-54.4 0.38-0.77
CM
% (n) 25.1 (103) 9.5 (43) < 0.001c 62.2 0.31
CI 21.1-29.5 7.1-12.5 47.4-72.8 0.21-0.46
AM
% (n) 60.3 (248) 23.8 (108) < 0.001c 60.6 0.25
CI 55.5-65.0 20.1-27.9 52.7-67.2 0.15-0.28
Anaemia
% (n) 80.1 (329) 28.9 (131) < 0.001c 64 0.10
CI 75.9-83.6 24.9-33.2 58.0-69.1 0.07-0.14
MA
% (n) 69.1 (284) 14.5 (66) < 0.001c 79 0.08
CI 64.5-73.4 11.6-18.1 73.5-83.3 0.05-0.12
aSignificant at P <0.05 level, csignificant at P <0.001 level.
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to 11.6 (1.9) g/dL (CI = 11.4-11.8 g/dL) with a mean
difference of 2.1 g/dL (CI = 1.9-2.4 g/dL). Children
who were malaria parasite positive in the follow-up
study had significantly higher (P <0.001) mean Hb,Table 2 Effect of age on the prevalence of malariometric indi





























aSignificant at P <0.05 level, csignificant at P <0.001 level.Hct, MCH, MCHC, and MCV when compared with
their baseline counterpart. On the other hand, the
mean RBC was significantly lower in malaria parasite
positive children in the follow-up study than those at
baseline (Table 4).ces
in years P-value
6-10% (n) 11-14% (n)
32.6 (134) 13.9 (57)
45.2 (205) 15.9 (72)
32.8 (44) 22.8 (13) 0.29
23.0 (47) 19.4 (14) 0.78
88.1 (118) 82.5 (47) 0.53
34.6 (71) 40.3 (29) 0.67
23.1 (31) 17.5 (10) 0.15
6.8 (14) 4.2 (3) 0.39
15.7 (21) 10.5 (6) <0.001c
12.7 (26) 23.6 (17) 0.049
29.1 (39) 21.1 (12) 0.39
8.8 (18) 8.3 (6) 0.76
59.0 (79) 61.4 (35) 0.92
22.4 (46) 30.6 (22) 0.34
78.4 (105) 68.4 (39) 0.03a
28.8 (59) 6.9 (5) <0.001c
66.4 (89) 59.6 (34) 0.103
14.1 (29) 1.4 (1) <0.001c
Table 3 Comparison of geometric mean parasite density per μL of blood within the age groups and study period
Age groups in years Baseline (2006) Follow-up (2013)
N GMPD ANOVA N GMPD ANOVA
P- value P- Value
≤5 186 1,003.4 62 1076.5
6-10 118 637.4 5.54 69 639.0 1.42
11-14 47 524.9 0.004§b 30 832.7 0.244§
Total 351 789.9 161 834.8
§Log of parasite counts used in the analysis, bSignificant at P <0.01 level.
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anaemia in the study population at baseline (59.6, 14.9,
6.3%) decreased significantly (P <0.001) to 24.4, 2.7 and
1.3%, respectively during follow-up as shown in Table 5.
The highest relative risk reduction in prevalence of
anaemia was observed in moderate anaemia (82.1%,
CI = 67.3-90.2% [14.9 to 2.7%]).
The prevalence of microcytosis, hypochromasia and
microcytic anaemia (MCV <73 fl and Hb <11 g/dL)
decreased significantly (P <0.001) from >55% in 2006
to <29% in 2013 (Figure 2). The occurrence of micro-
cytic anaemia in children in the follow-up survey had the
highest reduction in relative risk (86.3%, CI = 80.5-90.3%)
when compared with microcytosis (80.5%, CI = 75–84.8%)
and hypochromasia (59.1%, CI = 51.6-65.4%).
Discussion
Most parts of Cameroon have approached or met the
Roll Back Malaria (RBM) household ITN coverage of at
least 60% as reported by previous studies [9]. However,
malaria still remains a public health concern even
though LLINs were distributed freely in 2011. This study




















csignificant at P <0.001 level.enhanced malaria control measures on malariometric
and red cell indices in children in Muea, in the Mount
Cameroon area.
Parasitaemia is one of the indices used in estimating
the burden of malaria and the impact of interventions.
The prevalence of malaria parasitaemia is on the decline
in the Mount Cameroon area as revealed by the study.
Overall, the prevalence of malaria parasite obtained in the
follow-up study (36.6%) was lower than those obtained at
baseline (85.4%) and a similar study conducted in 2012
(44.3%) in this part of the Mount Cameroon area by
Kimbi et al. [21]. The achievement of a relative risk re-
duction in malaria parasite prevalence of 57.2% may be
credited to all the control efforts implemented by the
Cameroon government, through the NMCP in the
Ministry of Public Health. Some of the measures in-
cluded the free distribution of LLINs to all age groups,
as well as free treatment of malaria among children
less than five years of age. Also, the government intro-
duced several educative health campaigns on malaria
prevention in public and private media (radio and television
channels). Such messages included the recognition of com-
mon signs and symptoms of malaria and the need to getasite positive children at baseline and follow-up
Mean (SD) t-test Mean difference
P-value CI
9.4 (1.8) 10.80 1.8
11.3 (1.9) <0.001c 1.5-2.2
31.3 (5.0) 5.94 2.9
34.2 (5.3) <0.001c 1.9-3.9
19.0 (7.8) 9.86 6.6
25.6 (2.4) <0.001c 5.3-7.9
304.8 (58.3) 4.66 23.2
328.0 (14.8) <0.001c 13.4-33.1
64.7 (32.1) 4.92 13.5
78.2 (6.2) <0.001c 8.1-18.9
5.7 (2.0) −6.4 −1.1
4.5 (0.7) <0.001c - 1.5 - -0.8
Table 5 Variation in the different categories of anaemia in the study populations
Anaemia category
Period prevalence Relative risk
reduction (%)
Odds
ratioBaseline (2006) Follow-up (2013)
Mild
% (n) 59.6 (242) 24.4 (110) 58.7 0.22
CI 54.2-63.7 20.7-28.6 50.5-65.5 0.17-0.3
Moderate
% (n) 14.9 (61) 2.7 (12) 82.1 0.16
CI 11.8-18.7 1.53-4.6 67.3-90.2 0.08-0.30
Severe
% (n) 6.3 (26) 1.3 (6) 79.0 0.20
CI 4.4-9.13 0.6-2.9 49.6-91.3 0.08-0.49
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protective measures encouraged included eliminating
breeding sites by drainage of pools in which water collects,
regular collection of household refuse by designated au-
thorities to reduce container breeding of mosquitoes, fill-
ing up of pot-holes, chemical killing of mosquito larvae in
well defined and limited breeding sites and compulsory
monthly clean up of the environment by communities.
The study brings to light a change in morbidity in chil-
dren in the follow-up survey. Although not statistically
significant, the asexual GMPD/μL of blood in 2013 was
higher (834.8) than the baseline value (789.9). Further-
more, in the follow-up study, children in the 11–14 years
age group had a significantly higher (P = 0.04) GMPD/μL
of blood than their baseline equivalent. The highest preva-
lence of malaria parasite and the significant increase in
parasite density observed in children 11–14 years old, un-
like in the baseline study, probably reflects the manner of
usage of ITNs by children in the study area. Results from
the study indicate that while the effective use of ITNs in
2006 was comparable in the different age groups, in 2013
children in the 11–14 years age group registered a signifi-
cant decrease in usage. Consequently, they were more
exposed to infective mosquito bites than the other age
groups. This may have resulted in the high prevalence and
density of malaria parasite observed in this age group.
Hence, children in the 11–14 years age group most likely
did not acquire immunity to parasitization per se but mayFigure 2 Prevalence of microcytosis, hypochromasia and microcytic ahave acquired immunity that prevented the development
of febrile disease as the study revealed an increase in
asymptomatic malaria in the age group (Table 2). This is
in line with Bejon et al. [22] who reported a shift away
from febrile malaria to acquiring asymptomatic parasit-
aemia with increasing age. The asymptomatic parasit-
aemia may be beneficial in inducing and sustaining partial
immunity against malaria [23], although a significant
drawback is the suppression of Hct levels [24].
It is not surprising that children under five years re-
corded the highest parasitaemia when compared with
the older children in spite of their effective use of ITNs.
Children under five years are more vulnerable to the
disease in areas of high transmission [21,25] as naturally
acquired immunity builds up in older children following
repeated exposure to the parasite. In another study [22],
the use of ITNs was associated with remaining infection-
free rather than acquiring asymptomatic infection or
febrile malaria. The high effective use of ITNs in this age
group, culminating in a lack of exposure to infective mos-
quito bites, could have prevented the development of
blood stage immunity, the protective effect of living in a
high-transmission area [22], hence, the high parasitaemia
observed.
The prevalence of Plasmodium gametocytes, the sex-
ual, non-proliferating blood stage in the life cycle, sig-
nificantly reduced in the follow-up study. It is plausible
that the implementation of a highly gametocytocidal,naemia at baseline and during follow-up.
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amodiaquine-artesunate, as first-line treatment for uncom-
plicated malaria by the government of Cameroon, may have
contributed to the reduction in gametocyte prevalence.
However, malaria transmission is dependent on mosquito
vector dynamics, the proportion of humans with peripheral
gametocytaemia, and the infectiousness of circulating
gametocytes to mosquitoes. The reduction in prevalence
of peripheral gametocytaemia observed in the follow-up
survey is of utmost importance as this probably attests
to a decline in malaria transmission following a reduction
in the infectiousness of Anopheles mosquitoes.
Splenomegaly is the main clinical marker of endemicity
in P. falciparum transmission areas [27]. The minimal
reduction in the prevalence of splenomegaly when com-
pared with other malariometric indices indicates malaria
is still meso-endemic [28] in the study area. Worthy of
note is the significant change in morbidity with age when
both surveys were compared. Contrary to the baseline
trend, the follow-up study showed an increase in spleno-
megaly prevalence with age. Persistent parasitaemia from
treatment failure [29] and a pronounced immunological
response especially in children ≤ five years [25] are known
to contribute to splenic enlargement. However, with the
introduction of ACT as the first-line treatment for malaria
in Cameroon, the widespread use of ITNs and prompt
access to effective treatment in children, especially those
aged under five, the spleen rate is expected to decline.
While the increased prevalence of splenomegaly in chil-
dren age over ten years may be the consequence of
increased presence of malaria parasite and density in this
age group, the lowered spleen rate in children under five
years may be ascribed to the benefits of the therapeutic
actions of ACT and the effective use of ITNs. ACT is
given in all hospitals in Cameroon to children aged under
five with malaria, free of cost, a policy the government in-
stituted in 2010. The beneficial features of ACT include
rapid and substantial reduction of the parasite biomass,
rapid parasite clearance and effective action against multi-
drug resistant P. falciparum [30], thus preventing recru-
descence and multiple infections which may over work
the spleen, consequently leading to splenomegaly. Studies
indicate that the spleen-specific pitting function accounts
for a large fraction of parasite clearance in artemisinin-
treated patients [31].
The increase in mean Hb concentration from 9.4 (1.8)
in the baseline study to 11.3 (1.9) g/dL in the follow-up
study, regardless of the status, signifies a great improve-
ment in the health of children in this study area. WHO
and RBM recommend that anaemia be used as an add-
itional indicator to monitor malaria burden at commu-
nity level as interventions are nationally scaled-up [32].
The significant reduction in anaemia and MA at follow-
up suggests a substantial diminution in malaria-relatedmorbidity in the community. On the other hand, the
significant decline in morbidity related to malaria is not
unexpected in a community which benefits from free
ITNs, LLINs and ACT in the vulnerable group. In addition,
non-malaria-related intervention, such as regular deworm-
ing of school-age children carried out by the health author-
ities and parents, may have contributed to the improved
Hb levels and health of the children. Furthermore, the
acquisition of knowledge by caregivers/parents on the
health and nutritional status of their children following
the education on the outcome of the baseline study,
may have played a significant role in improving health
and well being in the community.
Even though both studies had as a limitation a small
number of children in the 11–14 years age group, it is un-
likely that the difference in numbers may have introduced
a bias as the mean difference in age was of no conse-
quence. The higher prevalence of anaemia in the ≤ five
years group with decreasing severity with age is in line
with previous studies that anaemia due to malaria is more
severe in younger children in areas of intense transmission
[25]. Children in this age group are more vulnerable to
infection with malaria than others with severe and poten-
tially fatal complications.
Studies by Korenromp et al. [2] reported the impact of
ITNs on anaemia to be more pronounced than that for
parasitaemia prevalence and CM, with moderate to severe
anaemia being a more sensitive measure to changes in
malaria exposure due to increasing coverage of malaria
interventions. Findings from the study attest to this as the
highest relative risk reduction in prevalence was observed
in moderate and severe anaemia indicating that the
nationwide free distribution of ITNs and use had a major
impact on the health of the children. Nonetheless,
although the proportion of effective users of ITNs in the
population was low, the non-effective users probably
benefitted from the reduction in mosquito vector popula-
tion achieved in the community from nets of effective
users, hence the reduction in anaemia and severity.
Results from the baseline survey indicated a prevalence
of 56% for microcytic anaemia to be a common finding
in the children examined when compared with 7.7% at
follow-up. Microcytic anaemia, a surrogate marker of
iron deficiency, is also a characteristic feature of anaemia
due to malaria [33]. The anaemia of P falciparum malaria
is typically normocytic and normochromic, with a notable
absence of reticulocytes, although microcytosis and hypo-
chromia may be present due to the very high frequency of
alpha- and beta-thalassaemia traits and/or iron deficiency
in many endemic areas [34]. However, Premji et al. [35]
reported a majority of children infected with P. falciparum
to be iron deficient. In a related study in the same area,
28% of the children with P. falciparum infections were
iron deficient albeit the majority had microcytic anaemia
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decline in microcytic anaemia observed in children at
follow-up was the result of a reduction in prevalence of
malaria parasitaemia. This consequently lends support to
the fact that malaria is a major contributor to microcytic
anaemia in the study population.
The primary limitation of the study is the lack of infor-
mation on the variation in consultations with children
under five years in health facilities following the com-
mencement of free treatment of malaria as inferences
have been made. However, irrespective of the age group,
all the children benefitted in the same way from the envi-
ronmental management instituted to control the breeding
of the mosquito vector and the distribution of LLINs.
Conclusions
The results from the studies suggest that even though a
greater majority of the population is in possession of an
ITN, less than half of the population use them effectively.
Although malaria is still meso-endemic, most malario-
metric indices declined and the red cell indices markedly
improved. Following interventions, anaemia (moderate to
severe) was a more sensitive measure to detect changes in
malaria exposure. Children in the 11–14 years age group
experienced a significant increase in malaria-related mor-
bidity, and microcytic anaemia was no longer a common
finding in children in the area.
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